CryoCor gains PMA for cyoablation therapy via convoluted regulatory path
This article was originally published in Clinica
Executive Summary
The US FDA has finally granted the pre-market approval (PMA) sought by CryoCor for its cardiac cryoablation system for the treatment of right atrial flutter.